BioMarin Pharmaceutical Total Current Liabilities 2010-2024 | BMRN
BioMarin Pharmaceutical total current liabilities for the quarter ending December 31, 2024 were $0.607B, a 48.43% decline year-over-year.
- BioMarin Pharmaceutical total current liabilities for 2024 were $0.607B, a 48.43% decline from 2023.
- BioMarin Pharmaceutical total current liabilities for 2023 were $1.177B, a 99.87% increase from 2022.
- BioMarin Pharmaceutical total current liabilities for 2022 were $0.589B, a 7.76% increase from 2021.